Accenture
ACN
181.29
-9.00
-4.73%
Accenture
US · ACN
#140 by market cap
Listed 1970
-4.73%
181.29
-9.00
-4.73%
Collector offline (last heartbeat: 75809s ago)
· 2026-09-18 19:59
Pre-market
188.95
-0.70%
After-hours
195.88
+8.05%
Overnight
190.00
-0.15%
- Market cap
- 110.94B
- P/E (TTM)i
- 14.48
- P/Bi
- 3.48
- EPSi
- 12.15
- Div yieldi
- 3.51%
- 52W posi
- 38%
Reader sentiment
Are you bullish or bearish on ACN?
Anonymous reader poll. Unscientific, not investment advice.
Revenue annual, last 8 years
Latest year +7.36% YoY
Margins
- Gross margin
- 31.91%
- Operating margin
- 15.56%
- Net margin
- 11.02%
Key ratios & quality
- Enterprise valuei
- 105.33B
- PEG ratioi
- 3.87
- Altman Z-Scorei
- 4.23
PEG uses trailing P/E against the 3-year net income growth rate (3.74%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.23, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 40.99B | 43.22B | 44.33B | 50.53B | 61.59B | 64.11B | 64.90B | 69.67B |
| Gross profit | 12.49B | 13.31B | 13.98B | 16.36B | 19.70B | 20.73B | 21.16B | 22.24B |
| Selling & admin expenses | 6.59B | 7.01B | 7.46B | 8.74B | 10.33B | 10.86B | 11.13B | 11.39B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 5.90B | 6.31B | 6.51B | 7.62B | 9.37B | 9.87B | 10.03B | 10.84B |
| Pretax profit | 5.81B | 6.25B | 6.77B | 7.76B | 9.20B | 9.14B | 9.70B | 10.27B |
| Tax | 1.59B | 1.41B | 1.59B | 1.77B | 2.21B | 2.14B | 2.28B | 2.44B |
| Net profit | 4.21B | 4.85B | 5.19B | 5.99B | 6.99B | 7.00B | 7.42B | 7.83B |
| Basic EPS | 6 | 7 | 8 | 9 | 11 | 11 | 12 | 12 |
| Diluted EPS | 6.34 | 7.36 | 7.89 | 9.16 | 10.71 | 10.77 | 11.44 | 12.15 |
| Line item | 2025-02 | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 |
|---|---|---|---|---|---|---|
| Revenue | 16.66B | 17.73B | 17.60B | 18.74B | 18.04B | 18.72B |
| Gross profit | 4.97B | 5.83B | 5.61B | 6.20B | 5.46B | 6.13B |
| Selling & admin expenses | 2.73B | 2.84B | 2.95B | 3.02B | 2.97B | 2.96B |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 2.24B | 2.98B | 2.67B | 3.18B | 2.49B | 3.18B |
| Pretax profit | 2.29B | 2.95B | 2.08B | 2.97B | 2.46B | 3.15B |
| Tax | 466.33M | 707.18M | 625.43M | 725.77M | 597.27M | 761.94M |
| Net profit | 1.82B | 2.24B | 1.45B | 2.24B | 1.86B | 2.39B |
| Basic EPS | 3 | 4 | 2 | 4 | 3 | 4 |
| Diluted EPS | 2.82 | 3.49 | 2.25 | 3.54 | 2.93 | 3.80 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 13.59B | 15.45B | 17.75B | 19.67B | 21.61B | 23.38B | 20.86B | 28.90B |
| Cash & ST investments | 5.06B | 6.13B | 8.51B | 8.17B | 7.89B | 9.05B | 5.01B | 11.48B |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 24.45B | 29.79B | 37.08B | 43.18B | 47.26B | 51.25B | 55.93B | 65.39B |
| Total current liabilities | 10.15B | 11.06B | 12.66B | 15.71B | 17.52B | 18.01B | 18.98B | 20.35B |
| Short-term debt | 5.34M | 6.41M | 763.88M | 756.24M | 716.77M | 795.23M | 1.67B | 843.49M |
| Long-term debt | 19.68M | 16.25M | 54.05M | 53.47M | 45.89M | 43.09M | 78.63M | 5.03B |
| Total liabilities | 13,724,495,000.00 | 14,962,189,000.00 | 19,579,420,000.00 | 23,078,729,000.00 | 24,516,302,000.00 | 24,786,712,000.00 | 26,764,115,000.00 | 33,153,930,000.00 |
| Total equity | 10.72B | 14.83B | 17.50B | 20.10B | 22.75B | 26.46B | 29.17B | 32.24B |
| Retained earnings | 7.95B | 10.42B | 12.38B | 13.99B | 18.20B | 19.32B | 23.08B | 21.02B |
| Line item | 2025-02 | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 |
|---|---|---|---|---|---|---|
| Total current assets | 25.31B | 27.42B | 28.90B | 28.07B | 28.01B | 28.94B |
| Cash & ST investments | 8.50B | 9.64B | 11.48B | 9.66B | 9.41B | 10.17B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 59.87B | 63.36B | 65.39B | 64.70B | 67.06B | 68.81B |
| Total current liabilities | 17.13B | 18.77B | 20.35B | 19.90B | 20.96B | 21.61B |
| Short-term debt | 806.34M | 839.34M | 843.49M | 842.92M | 868.76M | 863.74M |
| Long-term debt | 5.04B | 5.04B | 5.03B | 5.03B | 5.03B | 5.03B |
| Total liabilities | 29,687,808,000.00 | 31,812,514,000.00 | 33,153,930,000.00 | 32,776,181,000.00 | 34,289,201,000.00 | 35,298,848,000.00 |
| Total equity | 30.18B | 31.55B | 32.24B | 31.92B | 32.78B | 33.51B |
| Retained earnings | 25.21B | 26.45B | 21.02B | 22.15B | 22.80B | 24.03B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 6.03B | 6.63B | 8.22B | 8.98B | 9.54B | 9.52B | 9.13B | 11.47B |
| Depreciation & amortization | 926.78M | 892.76M | 1.77B | 1.89B | 1.03B | 1.06B | 1.08B | 1.37B |
| Free cash flow | 5.41B | 6.03B | 7.62B | 8.40B | 8.82B | 9.00B | 8.61B | 10.87B |
| Dividends paid | -1.71B | -1.86B | -2.04B | -2.24B | -2.46B | -2.83B | -3.24B | -3.70B |
| Stock buybacks / issuance | -1.89B | -1.84B | -1.96B | -2.64B | -2.77B | -2.83B | -3.11B | -3.27B |
| Ending cash balance | 5.06B | 6.13B | 8.42B | 8.17B | 7.89B | 9.05B | 5.00B | 11.48B |
| Line item | 2025-02 | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 |
|---|---|---|---|---|---|---|
| Operating cash flow | 2.85B | 3.68B | 3.91B | 1.66B | 3.82B | 3.79B |
| Depreciation & amortization | 285.97M | 292.01M | 497.10M | 296.03M | 314.44M | 307.94M |
| Free cash flow | 2.68B | 3.52B | 3.81B | 1.51B | 3.67B | 3.60B |
| Dividends paid | -928.99M | -923.89M | -921.73M | -1.01B | -1.01B | -995.33M |
| Stock buybacks / issuance | -1.24B | -1.29B | -317.78M | -1.86B | -1.39B | -731.50M |
| Ending cash balance | 8.49B | 9.63B | 11.48B | 9.65B | 9.40B | 10.17B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 42.04 | 38.58 | 32.52 | 32.34 | 33.04 | 28.75 | 26.92 | 25.82 |
| ROA %i | 17.23 | 17.62 | 15.28 | 14.72 | 15.21 | 13.95 | 13.56 | 12.66 |
| ROIC %i | 41.66 | 38.10 | 29.10 | 27.24 | 28.39 | 24.66 | 23.19 | 21.16 |
| 5-year avg ROE %i | 50.07 | 46.78 | 42.99 | 37.45 | 35.70 | 33.05 | 30.71 | 29.37 |
| EBIT margin %i | 14.01 | 14.52 | 15.36 | 15.48 | 15.01 | 14.33 | 15.04 | 15.07 |
| FCF / sales %i | 13.00 | 13.95 | 17.18 | 16.61 | 14.32 | 14.03 | 13.27 | 15.61 |
| Current ratioi | 1.34 | 1.40 | 1.40 | 1.25 | 1.23 | 1.30 | 1.10 | 1.42 |
| Quick ratioi | 1.24 | 1.29 | 1.29 | 1.14 | 1.12 | 1.18 | 0.98 | 1.30 |
| Debt / assetsi | 0.24 | 0.16 | 20.50 | 17.96 | 15.04 | 12.26 | 14.57 | 26.23 |
| LT debt / equityi | 0.19 | 0.11 | 16.01 | 14.08 | 11.80 | 9.16 | 8.65 | 23.53 |
| Interest coveragei | 298.26 | 273.26 | 205.84 | 131.46 | 195.34 | 193.31 | 165.48 | 45.94 |
| Revenue CAGR (3Y) %i | 7.59 | 7.49 | 7.01 | 7.22 | 12.54 | 13.09 | 8.70 | 4.19 |
| Net income CAGR (3Y) %i | 9.96 | 5.14 | 14.03 | 13.31 | 12.90 | 10.39 | 7.14 | 3.74 |
| FCF CAGR (3Y) %i | 12.67 | 13.06 | 19.55 | 15.79 | 13.54 | 5.71 | 0.86 | 7.22 |
| Line item | 2025-02 | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 |
|---|---|---|---|---|---|---|
| ROE %i | 27.26 | 27.27 | 25.82 | 25.35 | 25.30 | 24.95 |
| ROA %i | 13.82 | 13.53 | 12.66 | 12.22 | 12.05 | 11.79 |
| ROIC %i | 22.45 | 22.16 | 21.16 | 19.72 | 19.69 | 19.53 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 15.41 | 15.64 | 15.07 | 14.91 | 14.86 | 14.93 |
| FCF / sales %i | 14.50 | 14.96 | 15.61 | 16.28 | 17.33 | 17.21 |
| Current ratioi | 1.48 | 1.46 | 1.42 | 1.41 | 1.34 | 1.34 |
| Quick ratioi | 1.33 | 1.32 | 1.30 | 1.29 | 1.20 | 1.21 |
| Debt / assetsi | 27.56 | 26.72 | 26.23 | 26.57 | 26.75 | 26.30 |
| LT debt / equityi | 24.80 | 23.98 | 23.53 | 23.84 | 23.96 | 23.60 |
| Interest coveragei | 80.38 | 57.86 | 45.94 | 39.97 | 40.77 | 41.06 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-09-18 19:59:43 · For reference only, not investment advice.